VCYT - Financial Reports List - Veracyte, Inc. - IntrinsicAlpha

Veracyte, Inc. VCYT

Healthcare - Biotechnology - NASDAQ - US

$ 31.26

-1.73 %

$ 2.44 B

Market Cap

98.71

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	20.81%	118.07%	393.19%
Annual Report	FY	10-K	2024-12-31	23.46%	132.44%	118.81%
Quarterly Report	Q3	8-K	2024-09-30	28.58%	151.17%	137.86%
Quarterly Report	Q2	8-K	2024-06-30	26.69%	168.25%	158.45%
Quarterly Report	Q1	8-K	2024-03-31	17.50%	67.21%	59.74%
Quarterly Report	Q4	8-K	2023-12-31	22.29%	-636.03%	73.73%
Annual Report	FY	10-K	2023-12-31	21.76%	-103.51%	-108.84%
Quarterly Report	Q3	8-K	2023-09-30	19.20%	-239.54%	-227.88%
Quarterly Report	Q2	8-K	2023-06-30	23.96%	11.85%	24.99%
Quarterly Report	Q1	8-K	2023-03-31	21.60%	60.69%	26.87%

1